Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole in Invasive Fungal Infection
NCT00811642Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of posaconazole in invasive fungal infection (IFI), sponsored by Merck & Co.. Started Nov 2008; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00811642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811642.